Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma

PHASE2UnknownINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Treatment ResponseAdverse EventsFeasibility
Interventions
PROCEDURE

Photodynamic therapy

Photolon (Belmedpreparaty, Minsk, Republic of Belarus), was administered intravenously at a dose of 2.5 mg/kg at 3 hours before illumination. After advancing a catheter (7 F inner sheath of a plastic stent delivery catheter \[MAJ-1419; Olympus America, Center Valley, Pa., USA\]) across the biliary stricture using a 0.035-in guidewire, the cylindrical diffuser is inserted into a catheter at the level of the stricture to be treated. Photoactivation (660 nm with a light dose of 100-150J/cm2, and fluence of 0.8-1W/cm2; UPL- FDT; LEMT Research \& Development Private Unitary Enterprise, Minsk, Republic of Belarus) is performed

Trial Locations (2)

138-736

RECRUITING

Asan Medical Center, Seoul

Unknown

RECRUITING

Do Hyun Park, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT02725073 - Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma | Biotech Hunter | Biotech Hunter